Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LRRC8C divergent transcript (LRRC8C-DT) is annotated as a divergent, likely non-coding transcript neighboring the LRRC8C gene[4]. There is currently no substantive evidence that LRRC8C-DT encodes a functional protein product or has established biological, pharmacological, or disease relevance. Importantly, this should not be confused with the protein-coding gene Leucine-rich repeat-containing protein 8C (LRRC8C), which is a subunit of the volume-regulated anion channel (VRAC) and has been studied in cell biology and disease[1][2][3][5]. LRRC8C-DT itself has no reported molecular function, role as a drug target, biomarker utility, or safety relevance in the biomedical literature or curated gene/protein databases[4]. If your intent was to target the VRAC protein subunit (LRRC8C), please clarify, as the information here refers strictly to the divergent transcript LRRC8C-DT, which lacks demonstrated molecular or therapeutic importance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LRRC8C divergent transcript (LRRC8C-DT).